POTI', FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.501
EU - Europa 538
AS - Asia 161
OC - Oceania 3
SA - Sud America 2
Totale 2.205
Nazione #
US - Stati Uniti d'America 1.497
GB - Regno Unito 172
IT - Italia 127
SE - Svezia 103
CN - Cina 50
DE - Germania 47
HK - Hong Kong 46
UA - Ucraina 24
TR - Turchia 17
FR - Francia 16
BG - Bulgaria 15
SG - Singapore 12
FI - Finlandia 10
MY - Malesia 9
VN - Vietnam 9
ID - Indonesia 7
BE - Belgio 6
IN - India 4
CA - Canada 3
CZ - Repubblica Ceca 3
IR - Iran 3
JP - Giappone 3
AU - Australia 2
CH - Svizzera 2
IE - Irlanda 2
LT - Lituania 2
NO - Norvegia 2
AT - Austria 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 2.205
Città #
Fairfield 253
Chandler 148
Southend 140
Woodbridge 131
Seattle 117
Ashburn 114
Houston 101
Cambridge 91
Wilmington 86
Ann Arbor 68
Nyköping 68
Dearborn 59
Modena 58
Hong Kong 46
Jacksonville 44
Beijing 15
Eugene 15
Princeton 15
Sofia 15
Izmir 14
San Diego 13
New York 11
Redwood City 11
Dong Ket 9
London 9
Milan 9
Boardman 8
Bremen 8
Fremont 8
Helsinki 8
Ferrara 7
Singapore 7
Brussels 6
Falls Church 6
Jakarta 6
Kunming 5
Leawood 5
Phoenix 4
Segrate 4
Shanghai 4
Ardabil 3
Corciano 3
Guangzhou 3
Imola 3
Munich 3
Napoli 3
Ottawa 3
Zhengzhou 3
Bologna 2
Brno 2
Cupra Marittima 2
Dublin 2
Frankfurt am Main 2
Hefei 2
Livorno 2
Norwalk 2
Tokyo 2
Acton 1
Amsterdam 1
Auckland 1
Augusta 1
Bangalore 1
Canberra 1
Casalgrande 1
Cerveteri 1
Chisinau 1
Chiswick 1
Clearwater 1
Cuauhtémoc 1
Dongguan 1
Dubendorf 1
Edinburgh 1
Ergolding 1
Esslingen am Neckar 1
Forlì 1
Fuzhou 1
Grafing 1
Hebei 1
Hounslow 1
Hyderabad 1
Islington 1
Kuala Lumpur 1
Langhirano 1
Lishui 1
Los Angeles 1
Melita 1
Monmouth Junction 1
Nanchang 1
Nanjing 1
Novokuznetsk 1
Oslo 1
Pavia 1
Philadelphia 1
Quito 1
Redmond 1
Reggio Emilia 1
Reggio Nell'emilia 1
Rockville 1
Rome 1
Saint Louis 1
Totale 1.831
Nome #
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 275
'Spare' Luteinizing Hormone Receptors: Facts and Fiction. 204
KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R-/- Mice. 191
Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice 190
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R-/-) mice. 174
Osteocytes Specific GSK3 Inhibition Affects In Vitro Osteogenic Differentiation. 168
Alcohol Pattern Consumption Differently Affects the Efficiency of Macrophage Reverse Cholesterol Transport in Vivo 155
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis 153
Wisp2 overexpression induced by short Teriparatide treatment affects IDG-SW3 osteogenic differentiation. 121
Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment 117
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 114
Muscle-to-bone crosstalk: the Wnt/-catenin pathway is a candidate mechanism mediating the signalling between C2C12 muscle cells and 2T3 osteoblasts 114
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice 109
Gnrh antagonists produce differential modulation of the signaling pathways mediated by gnrh receptors 107
Polyphenol health effects on cardiovascular disorders: myth or truth? "Le basi farmacologiche dei nutraceutici" 43
Totale 2.235
Categoria #
all - tutte 9.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 33 14 29 27 51 84 95 58 49 20 30 15
2020/2021567 48 24 46 65 76 70 36 37 30 60 57 18
2021/2022364 21 17 37 33 7 20 13 36 50 20 65 45
2022/2023353 46 56 35 47 36 44 6 23 35 3 12 10
2023/2024175 5 10 11 26 20 12 22 34 0 3 10 22
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 2.235